Keywords: biological disease-modifying anti-rheumatic drugs, biologics, conventional disease-modifying anti-rheumatic drugs, hand osteoarthritis, hydroxychloroquine, IL-1 inhibitors, IL-6 inhibitors, methotrexate, osteoarthritis, TNF- inhibitors
Disease-modifying anti-rheumatic drugs (DMARDs) methotrexate leflunomide hydroxychloroquine sulfasalazine.
Recommendations on biologic and targeted synthetic disease modifying anti- rheumatic drugs (b/tsDMARDs) for the treatment of rheumatic diseases. USEFUL LINKS.
An acronym for disease-modifying anti-rheumatic drugs, DMARDs are medicines that work to modify the course of the disease. Traditional DMARDs include
Disease-modifying anti-rheumatic drugs (DMARDs) methotrexate leflunomide hydroxychloroquine sulfasalazine.
These are often divided into main 2 types: disease-modifying anti-rheumatic drugs (DMARDs) and biological treatments. Disease-modifying anti-rheumatic drugs (
These are often divided into main 2 types: disease-modifying anti-rheumatic drugs (DMARDs) and biological treatments. Disease-modifying anti-rheumatic drugs (
An acronym for disease-modifying anti-rheumatic drugs, DMARDs are medicines that work to modify the course of the disease. Traditional DMARDs include
Conventional disease-modifying anti-rheumatic drugs are synthetic drugs that modify disease rather than just alleviating symptoms. They include
Comments
Boyd